These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33371835)

  • 21. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
    Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
    Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective.
    Magrone T; Magrone M; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):807-811. PubMed ID: 32338224
    [No Abstract]   [Full Text] [Related]  

  • 24. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
    Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED
    Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs acting on the renin-angiotensin system and SARS-CoV-2.
    Vitiello A; Pelliccia C; Ferrara F
    Drug Discov Today; 2021 Apr; 26(4):870-874. PubMed ID: 33486116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
    Guney C; Akar F
    J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
    Gupta VK; Murthy MK; Patil S
    Curr Drug Targets; 2021; 22(10):1149-1157. PubMed ID: 33243116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
    Egilmezer E; Rawlinson WD
    Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.
    Mancia G
    Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role and significance of angiotensin-converting enzyme 2 peptides in the treatment of coronavirus disease 2019.
    Liu Y; He H; Huang H
    J Clin Lab Anal; 2021 Jun; 35(6):e23789. PubMed ID: 33951227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE2 and SARS-CoV-2: Tissue or Plasma, Good or Bad?
    Wenzel UO; Kintscher U
    Am J Hypertens; 2021 Apr; 34(3):274-277. PubMed ID: 33151267
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of preventive strategies: novel high-CBD
    Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.
    Lores E; Wysocki J; Batlle D
    Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE2 in the renin-angiotensin system.
    Verano-Braga T; Martins ALV; Motta-Santos D; Campagnole-Santos MJ; Santos RAS
    Clin Sci (Lond); 2020 Dec; 134(23):3063-3078. PubMed ID: 33264412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
    Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
    J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.